LY3202626
low-dose CNS-penetrant BACE inhibitor 90% red. of CSF Aβ in Ph. II at 9.2 mg / discont. from opt. vs. CatD and dose red. of prior leads Journal of Medicinal Chemistry Eli Lilly, Indianapolis, US
Molecules of the Month - June 2021
Molecules of the Month
- H3B-8800
- TPX-0131
- RMC-4529
- ART558
- PF-60873600
- LY3202626
- AZD8154
- vesatolimod
- M-1121
- CHF-6001
- VNRX-7145
- compound 21
- BIO-32546
- leriglitazone